GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer
Yao Long(Central South University), Yongguang Tao(Central South University), Jingyue Sun(Central South University), Jielin Chen(Central South University), Na Liu(Shenyang Pharmaceutical University), Weiwei Lai(Central South University), Shuang Liu(Central South University), Desheng Xiao(Central South University), Ying Shi(Central South University), Haiyan Wang(Chongqing Medical University), Ling Chen(Central South University), Zuli Wang(Central South University), Xin Peng(National Clinical Research Center for Digestive Diseases), Jiaxing Guo(Central South University), Long Shu(Zhejiang Hospital)
Cited by 43
Related Papers
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
|Signal Transduction and Targeted Therapy|2023|289
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
|Biomedicine & Pharmacotherapy|2024|109
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers
|Journal for ImmunoTherapy of Cancer|2021|77
PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma
|Oncogene|2022|57
DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
|Epigenetics & Chromatin|2019|54